Pedro Isaacsson

77 posts

Pedro Isaacsson banner
Pedro Isaacsson

Pedro Isaacsson

@PedroIsaacsson

Medical Oncologist at Johns Hopkins Hospital - Clinical & Research Postdoctoral Fellowship Genitourinary cancers.

Katılım Nisan 2019
1.4K Takip Edilen208 Takipçiler
Pedro Isaacsson retweetledi
Denis Jardim
Denis Jardim@jardim_denis·
It is a pleasure to continue contributing to @LACOG_group with this Great Team @diogodrigues @drdanielvargas @fedelosco @PedroIsaacsson
LACOG - Latin American Cooperative Oncology Group@LACOG_group

It is a pleasure to introduce to you the new board, educational and scientific steering committee of the LACOG Genitourinary Group. The new formation of the group will run from 2024 to 2026,and will continue with the goal of developing new clinical and epidemiological studies.

English
0
2
9
754
Pedro Isaacsson retweetledi
Eric Feigl-Ding
Eric Feigl-Ding@DrEricDing·
HORRIFYING #COVID19 death curve in one of wealthiest cities in Brazil— Porto Alegre is capital of Rio Grande do Sul— with many top-notch hospitals with better rating than most US🏥. And their health system still collapsed under #P1. Imagine now rest of 🇧🇷. (HT @alexaguiarpoa)
Eric Feigl-Ding tweet media
English
95
1.4K
2.9K
0
Pedro Isaacsson retweetledi
Neeraj Agarwal, MD, FASCO
Neeraj Agarwal, MD, FASCO@neerajaiims·
Results reinforce my confidence in IOs in #ProstateCancer 👉🏻 Finally OS (pre-specified endpoint) is significantly higher with IPI in postdocetaxel mCRPC, in a phase 3 trial we started 10 yrs ago under #KarimFizazi leadership. bit.ly/2YcebHo @OncoAlert Thanks @EUplatinum
Neeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet media
European Urology@EUplatinum

Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel mCRPC Identifies an Excess of Long-term Survivors #VisualAbstract @AlbertoBossial @HouedeNadine @neerajaiims buff.ly/3awcpWw

Holladay, UT 🇺🇸 English
2
34
71
0
Pedro Isaacsson retweetledi
Arjun Gupta
Arjun Gupta@guptaarjun90·
The great @DrArsenOsipov, Chief Fellow at @HopkinsMedicine #Oncology, advises Research Fellows at his graduation talk. Have learnt a tremendous amount from him the last 2 years. Fabulous peer mentor to me, and dozens of us! Will miss you, brother. cc: @kamarrone
Arjun Gupta tweet media
English
5
19
89
0
Pedro Isaacsson retweetledi
Journal of Clinical Oncology
Journal of Clinical Oncology@JCO_ASCO·
CDK12-Altered Prostate Cancer: Clinical Features & Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, & PD-1 Inhibitors fal.cn/37OQ4 #pcsm #JCOPO
Journal of Clinical Oncology tweet media
English
0
3
3
0
Ramy Sedhom, MD, FASCO
Ramy Sedhom, MD, FASCO@ramsedhom·
Our fellow-led QIA project in @JOP_ASCO ascopubs.org/doi/full/10.12… We aimed to improve pall care utilization! Notable Barriers: ⚠️orders hard to find in EMR ⚠️multiple consulting mechanisms (phone/EMR/email) ⚠️EMR request did not activate formal consult ⚠️no centralized scheduler
Ramy Sedhom, MD, FASCO tweet media
English
2
4
10
0
Pedro Isaacsson retweetledi
Neeraj Agarwal, MD, FASCO
Neeraj Agarwal, MD, FASCO@neerajaiims·
CDK12 altered metastatic prostate cancer: suboptimal response to abi/enza, taxanes or PARP inhibitors but encouraging signal on Rx with PD-1/L1i. Honored to be a part of this wonderful multi-center effort led by @EAntonarakis @ASCO_pubs @JCOPO_ASCO Time for a randomized trial.
Neeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet mediaNeeraj Agarwal, MD, FASCO tweet media
Panagiotis Vlachostergios@Panos_Vlach

Lots of interest for CDK12-altered #prostatecancer @JCOPO_ASCO @ASCO_pubs.2multictr #PrecisionMedicine works on responses2standard tx, #Immunotherapy @EAntonarakis @neerajaiims @DrScottTagawa @cnsternberg,R.Dreicer,O.Sartor,M.Hussain.ascopubs.org/doi/full/10.12…

Holladay, UT 🇺🇸 English
2
26
55
0
Pedro Isaacsson retweetledi
Johns Hopkins Medicine
Johns Hopkins Medicine@HopkinsMedicine·
#Cancer in the lead – but not for long. Certain proteins help cancer cells thrive, but we may be able to eliminate that advantage.
English
1
21
50
0
Pedro Isaacsson retweetledi
Denis Wirtz
Denis Wirtz@deniswirtz·
The economic impact of @JohnsHopkins: Hopkins is Maryland’s largest employer, a major purchaser of goods and services, a sponsor of construction projects and a magnet for students and visitors. In FY17, Hopkins accounted for >$12 billion in economic output and 105,800 jobs.
Denis Wirtz tweet mediaDenis Wirtz tweet mediaDenis Wirtz tweet mediaDenis Wirtz tweet media
English
0
13
46
0

Keşfet

@LACOG_group @diogodrigues @drdanielvargas @fedelosco @alexaguiarpoa @OncoAlert @EUplatinum @EAntonarakis